Berenberg lowered the firm’s price target on GSK (GSK) to 1,600 GBp from 1,820 GBp and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- GSK announces EC approved single-vial presentation of Menveo
- GSK announces FDA accepeted for review a BLA for Blenrep
- Trump Trade: Trump Media considers developing crypto payment service
- Trump expected to pick Martin Makary to head FDA, Reuters reports
- GSK announces Japan’s MHLW approved application to extend indication of Arexvy